Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
University of Nebraska
University of Nebraska
Vanderbilt-Ingram Cancer Center
National Institutes of Health Clinical Center (CC)
Fuda Cancer Hospital, Guangzhou
Fuda Cancer Hospital, Guangzhou
Vanderbilt University
SWOG Cancer Research Network
Vanderbilt-Ingram Cancer Center
University of California, San Francisco